Capital Research Reports 4.9% Passive Holding in SiriusPoint (SPNT)

Rhea-AI Filing Summary

Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership of 5,700,000 shares of SiriusPoint Ltd., representing 4.9% of the approximately 116.6 million shares outstanding. The filing is made under Rule 13d-1(b), indicating a passive disclosure for holdings under 5%. The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The disclosure clarifies voting and dispositive power are held solely by the reporting person.

Insights

Financial Analyst

TL;DR Institutional investor reports a modest 4.9% passive stake; disclosure indicates no intent to seek control.

The Schedule 13G amendment shows Capital Research Global Investors as the beneficial owner of 5,700,000 shares, or 4.9% of SiriusPoint's common stock. Filing under Rule 13d-1(b) and the Item 10 certification signal this is a passive holding held in the ordinary course of business. For investors, this is a transparent record of institutional interest but does not, by itself, imply strategic influence or control over corporate decisions.

Corporate Governance Expert

TL;DR Passive institutional ownership disclosed; certification explicitly denies intent to influence control.

The amendment reports sole voting and dispositive power for the 5.7M shares with no shared powers, and includes a certification that the shares were not acquired to affect control. From a governance perspective, the filing documents a meaningful institutional position short of the 5%+ thresholds that typically trigger heightened takeover or activist scrutiny. The disclosure improves transparency without signaling governance change.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

SiriusPoint Ltd.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G8192H106

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G8192H106

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,700,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,700,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,700,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SiriusPoint Ltd.
(b)	Address of issuer's principal executive offices: ONE WORLD TRADE CENTER, 285 FULTON STREET, 47TH FLOOR, NEW YORK, NY 10007, United States of America
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: G8192H106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 5,700,000 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 5,700,000 shares or 4.9% of the 116,588,957 shares believed to be outstanding.
(b)	Percent of class: 4.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 5,700,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 5,700,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	08/05/2025

FAQ

How many SiriusPoint (SPNT) shares does Capital Research own?

The filing reports 5,700,000 shares beneficially owned by Capital Research Global Investors.

What percentage of SPNT does Capital Research's holding represent?

The reported holding represents 4.9% of the company’s outstanding common stock.

Was the Schedule 13G/A filed as a passive disclosure or for control purposes?

The filing was made under Rule 13d-1(b) and includes a certification that the shares are held in the ordinary course of business and not to change or influence control.

Does the reporting person have voting or dispositive power over the shares?

Yes. The filing states the reporting person has sole voting power and sole dispositive power over the 5,700,000 shares, with no shared powers reported.

Who signed the filing on behalf of Capital Research and when was it signed?

The filing was signed by Jae Won Chung, Vice President and Senior Counsel II at Capital Research and Management Company, and the signature date in the filing is 08/05/2025.